Multispecificity of drug transporters: Probing inhibitor selectivity for the human drug efflux transporters ABCB1 and ABCG2

被引:35
作者
Cramer, Joerg
Kopp, Stephan
Bates, Susan E.
Chiba, Peter
Ecker, Gerhard F.
机构
[1] Institute of Medical Chemistry, Medical University of Vienna, 1090 Wien
[2] Department of Medicinal Chemistry, University of Vienna, 1090 Wien
[3] BioChemInformatics, Intervet Innovation GmbH, 55270 Schwabenheim, Zur Probstei
[4] Medical Oncology Branch, National Cancer Institute, Building 10, Bethesda, MD 20892
基金
奥地利科学基金会;
关键词
D O I
10.1002/cmdc.200700160
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Multidrug resistance transporters P-glycoprotein/ABCB1 and ABCG2 limit the effect of a large number of cytostatic and cytotoxic drugs by energy-dependent efflux. In experimental models, pump inhibitors reestablish sensitivity towards these drugs. Both transporters demonstrate remarkably broad and partly overlapping substrate specificity. Propafenone analogues are inhibitors of a large number of drug efflux pumps including P-glycoprotein and ABCG2 as well as the microbial pumps. Here the two human ABC transporters ABCB1 and ABCG2 have been studied with respect to interaction with this class of compounds. Data indicate that within the same chemical scaffold, selectivity indices span three orders of magnitude. Compounds with the highest selectivity indices contain a non-ionizable nitrogen atom. Qualitative and quantitative pharmacophore models indicate that hydrophobicity, the number of rotatable bonds, and the number of H-bond acceptors ore key features for both activity and selectivity.
引用
收藏
页码:1783 / 1788
页数:6
相关论文
共 27 条
[1]   P-glycoprotein: from genomics to mechanism [J].
Ambudkar, SV ;
Kimchi-Sarfaty, C ;
Sauna, ZE ;
Gottesman, MM .
ONCOGENE, 2003, 22 (47) :7468-7485
[2]   Binding of small molecules to an adaptive protein-protein interface [J].
Arkin, MR ;
Randal, M ;
DeLano, WL ;
Hyde, J ;
Luong, TN ;
Oslob, JD ;
Raphael, DR ;
Taylor, L ;
Wang, J ;
McDowell, RS ;
Wells, JA ;
Braisted, AC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :1603-1608
[3]   Modulation of P-glycoprotein mediated drug accumulation in multidrug resistant CCRF VCR-1000 cells by chemosensitisers [J].
Boer, R ;
Gekeler, V ;
Ulrich, WR ;
Zimmermann, P ;
Ise, W ;
Schodl, A ;
Haas, S .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (05) :857-861
[4]   SYNTHESIS, PHARMACOLOGICAL ACTIVITY, AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF A SERIES OF PROPAFENONE-RELATED MODULATORS OF MULTIDRUG-RESISTANCE [J].
CHIBA, P ;
BURGHOFER, S ;
RICHTER, E ;
TELL, B ;
MOSER, A ;
ECKER, G .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (14) :2789-2793
[5]   A pharmaeophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR [J].
Cianchetta, G ;
Singleton, RW ;
Zhang, M ;
Wildgoose, M ;
Giesing, D ;
Fravolini, A ;
Cruciani, G ;
Vaz, RJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (08) :2927-2935
[6]   A multidrug resistance transporter from human MCF-7 breast cancer cells [J].
Doyle, LA ;
Yang, WD ;
Abruzzo, LV ;
Krogmann, T ;
Gao, YM ;
Rishi, AK ;
Ross, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15665-15670
[7]   Structure-activity relationship studies on benzofuran analogs of propafenone-type modulators of tumor cell multidrug resistance [J].
Ecker, G ;
Chiba, P ;
Hitzler, M ;
Schmid, D ;
Visser, K ;
Cordes, HP ;
Csollei, J ;
Seydel, JK ;
Schaper, KJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (24) :4767-4774
[8]  
Ecker G, 1999, MOL PHARMACOL, V56, P791
[9]  
ECKER G, 2001, RRD MED CHE, V1, P121
[10]  
Ecker GF, 2005, CHIM OGGI, V23, P39